IMPLEMENTATION OF QBD APPROACH TO DEVELOP AND VALIDATE ANALYTICAL METHOD FOR SIMULTANEOUS ESTIMATION OF DULOXETINE HYDROCHLORIDE AND METHYLCOBALAMIN IN PHARMACEUTICAL DOSAGE FORM BY HPTLC METHOD
Keywords:
Duloxetine HCl (DUL) and Methylcobalamin (MEC), Quality by Design (QbD), HPTLC, ValidationAbstract
Objective: To develop and validate High-Performance Thin Layer Chromatography (HPTLC) analytical method for the determination of Duloxetine Hydrochloride (DUL) and Methylcobalamin (MEC) in the standard mixture and pharmaceutical capsule dosage form by implementing Quality by the Design (QbD) approach.
Methods: The chromatographic separation was performed on aluminium plates precoated by silica gel 60 F-254 using propanol: water: 25% v/v ammonia solution (9:2:1, v/v/v) as a mobile phase which was optimized with the help of a design expert. Densitometric analysis was carried out in the absorbance mode at 280 nm.
Results: Compact spots for Duloxetine HCl and Methylcobalamin were found at retardation factor (Rf) value of 0.77±0.02 and 0.55±0.03, respectively. The linear regression analysis data for the calibration plots showed correlation coefficient 0.9989 and 0.999 with a concentration range of 1200-3600 ng/spot and 60-180 ng/spot for Duloxetine HCl and Methylcobalamin respectively. Limit of detection (LOD) and limit of quantification (LOQ) was found to be 113.39 and 343.62 ng for Duloxetine HCl and 6.68 and 20.24 ng for Methylcobalamin, respectively. The method was validated for precision, accuracy, robustness, LOD and LOQ according to ICH Q2 R1 guidelines.
Conclusion: A new, simple, accurate, and precise HPTLC analytical method has been developed and validated for the determination of Duloxetine HCl and Methylcobalamin in pharmaceutical capsule dosage form by QbD concept in favour of fewer trials and error-free experimentation for the optimization process. The method seems to be suitable for the quality control in the pharmaceutical industry because of its sensitivity, simplicity, and selectivity.
Keywords: Duloxetine HCl (DUL), Methylcobalamin (MEC), Quality by Design (QbD), HPTLC, Validation
Downloads
References
Yu LX. Pharmaceutical quality by design: product & process development, understanding, and control. Pharm Res 2008;25:781-91.
Monks KE, Molnar I, Rieger HJ. Expanding the term Design Space†in high-performance liquid chromatography (I). J Pharm Biomed Anal 2011;56:874-9.
Krull I, Swartz M, Turpin J, Lukulay PH, Verseput R. A quality-by-design methodology for rapid LC method development, part-I. LC-GC North Am 2008;26:1190-7.
O'Neil MJ, Heckelman PE, Koch CB. The merck index: an encyclopaedia of chemicals, drugs, and biological. 14th edition. Merck and Co. Inc., Whitehouse station (NJ); 2006. p. 3465.
Turcotte JE, Debonnel G, de Montigny C, Hébert C, Blier P. Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. Neuropsychopharmacol 2001;24:511-21.
Chalon SA, Granier LA, Vandenhende FR, Bieck PR, Bymaster FP, Joliat MJ, et al. Duloxetine increases serotonin and norepinephrine availability in healthy subjects: a double-blind, controlled study. Neuropsychopharmacology 2003;28: 1685-93.
Mishra L. In: Drug today. 1st edition. Lorina Publications Inc., Delhi (IN); 2006. p. 489.
Lantz RJ, Gillespie TA, Rash TJ, Kuo F, Skinner M, Kuan HY, et al. Metabolism, excretion, and pharmacokinetics of duloxetine in healthy human subjects. Drug Metab Dispos 2003;31:1142-50.
Michel MC, Oelke M. Duloxetine in the treatment of stress urinary incontinence. Women's Health 2005;1:345-58.
Bauer M, Moller HJ, Schneider E. Duloxetine: a new selective and dual-acting antidepressant. Expert Opin Pharmacother 2006;7:421-7.
Heudi O, Kilinc T, Fontannaz P, Marley E. Determination of vitamin B12 in food products and in premixes by reversed-phase high performance liquid chromatography and immunoaffinity extraction. J Chromatogr A 2006;1101:63-8.
Japanese Pharmacopeia. Ministry of health, labour and welfare; 2007;15:844-5.
Prabu SL, Shahnawaz S, Dineshkumar C, Shirwaikar A. Spectrofluorimetric method for determination of duloxetine hydrochloride in bulk and pharmaceutical dosage forms. Indian J Pharm Sci 2008;70:502-3.
Thejaswini JC, Gurupadayya BM, Ranjith kumar K. Quantitative determination of duloxetine HCl in human plasma by the GC-FID method. Int J Pharm Pharm Sci 2013;5:405-8.
Brenna E, Frigoli S, Fronza G, Fuganti C, Malpezzi L. Isolation and characterization of a phenolic impurity in a commercial sample of duloxetine. J Pharm Biomed Anal 2007;43:1573-5.
Jansen PJ, Oren PL, Kemp CA, Maple SR, Baertschi SW. Characterization of impurities formed by the interaction of duloxetine HCl with enteric polymers hydroxypropyl methylcellulose acetate succinate and hydroxypropyl methylcellulose phthalate. J Pharm Sci 1998;87:81-5.
Johnson JT, Oldham SW, Lantz RJ, DeLong AF. A high performance liquid chromatographic method for the determination of duloxetine and desmethyl duloxetine in human plasma. J Liq Chromatogr Related Technol 1996; 19:1631-41.
Pankaj S, Mariappan TT, Banerjee UC. High-performance liquid chromatographic method for the simultaneous estimation of the key intermediates of duloxetine. Talanta 2005;67:975-8.
Olsen BA, Argentine MD. HPLC method development for duloxetine hydrochloride using a combination of computer-based solvent strength optimization and solvent selectivity mixture design. J Liq Chromatogr Related Technol 1996;19:1993-2007.
Chhalotiya UK, Bhatt KK, Shah DA, Baldania SL. Development and validation of a stability-indicating RP-HPLC method for duloxetine hydrochloride in its bulk and tablet dosage form. Sci Pharm 2010;78:857-68.
Sejal K, Patel SK, Patel NJ, Patel KM, Patel PU, Patel BH. Estimation of duloxetine hydrochloride in pharmaceutical formulations by RP-HPLC method. Indian J Pharm Sci 2008;70:825-7.
Patel SK, Patel NJ, Prajapati AM, Patel DB, Patel SA. Stability indicating RP-HPLC method development and validation for duloxetine hydrochloride in tablets. J AOAC Int 2010;93:123-32.
Narasimharao R, Laxmi RA, Sanjay KC, Kapil C, Chaitanya M. Method development and validation of duloxetine hydrochloride by RP-HPLC. Int J Res Pharm Biomed Sci 2011;2:1335-40.
Laha TK, Mishra G, Sen S. High-performance liquid chromatographic analysis of duloxetine and its metabolites in rat liver microsomes and characterization of in vitro microsomal metabolites through retro-synthesis followed by NMR and MS study. Int J Pharm Pharm Sci 2013;5:712-6.
Dasari S, Viriyala RK, Santosh K, Kumari A, Ravikumar B, Bisht S. A validated RP-HPLC method for the analysis of duloxetine hydrochloride in pharmaceutical dosage forms. Pharm Globale 2010;1:1-3.
Rao DD, Sait SS, Reddy AM, Chakole D, Reddy YR, Mukkanti K. Analysis of duloxetine hydrochloride and its related compounds in pharmaceutical dosage forms and in vitro dissolution studies by a stability indicating UPLC. J Chromatogr Sci 2010;48:819-24.
Saravanan J, Shajan A, Joshi NH, Varatharajan R, Valliappan KA. Simple and validated RP-HPLC method for the estimation of methylcobalamin in bulk and capsule dosage form. Int J Chem Pharm Sci 2010;1:13-6.
Kannapan N, Nayak SP, Venkatachalam T, Prabhakaran V. Analytical RP-HPLC method for development and validation of pregabalin and methylcobalamin in combined capsule formulation. J Appl Chem Res 2010;13:85-9.
Ismail Y, Chandrasekhar KB, Gunasekaran V. A new stability indicating UPLC method development and validation for the simultaneous estimation of duloxetine and mecobalamin in bulk and in its dosage forms. Int J Pharm Pharm Sci 2014;7:273-9.
Dhaneshwar SS, Deshpande P, Patil M, Vadnerkar G, Dhaneshwar SR. Development and validation of an HPTLC method for estimation of duloxetine hydrochloride in bulk drug and in tablet dosage form. Indian J Pharm Sci 2008;70:233-6.
Sheikh S, Siddiqui AW, Tariq Masroor M, Arora V. Stability-indicating HPTLC method for determination of duloxetine hydrochloride in bulk drug and tablet formulation. Chromatogr Res Int 2011:1-5. Doi.org/10.4061/2011/404189. [Article in Press]
Sharma MC, Sharma S, Sharma AD. A validated densitometric method for duloxetine hydrochloride in pharmaceutical dosage form. J Pharm Res 2011;4:1538-43.
Kalyankar TM, Panchakshari PP, Wadher SJ, Pekamwar SS. Simultaneous estimation of duloxetine and methylcobalamin in combined dosage form by ultra-violet spectrophotometry. Int J PharmTech Res 2013;5:1572-80.
Shete AS, Lade PD, Inamdar SJ, Kumbhar SS, Mhadeshwar AP. Simultaneous estimation of duloxetine hydrochloride and methylcobalamin by UV spectroscopic method. Int J Pharm 2013;3:734-40.
Tala P, Paghadar B, Dhudashia K, Bhaliya T, Nariya A. Analytical method development and validation for simultaneous estimation of duloxetine hydrochloride and methylcobalamin in their pharmaceutical dosage form by absorption correction method. Int J Res Pharm Nano Sci 2013;2:213-20.
Sharma MC, Sharma AD. Simultaneous estimation and validation of gabapentin and methylcobalamin in tablet dosage form, hydrotropic approach. Drug Invent Today 2011;3:95-7.
Galande VR, Baheti KG, Dehghan MH. UV-Vis spectrophotometric method for estimation of gabapentin and methylcobalamin in bulk and tablet. Int J ChemTech Res 2010;2:695-9.
Sengamalam R, Ravindran M, Gunjan M, Meena S. Analytical method development and dissolution profile of duloxetine and methylcobalamin by Vierodt's method. J Pharm Res 2011;4:449-51.
Goti PP, Patel PB. Development and validation of a ratio-derivative spectrophotometric method for simultaneous estimation of gabapentin, methylcobalamin and alpha lipoic acid in tablet formulation. J Pharm Res 2013;6:609-14.
Kamila MM, Mondal N, Ghosh LK. A validated UV spectrophotometric method for determination of duloxetine hydrochloride. Die Pharm 2007;62:414-5.
Ganesan M, Solairaj P, Rajesh SC, Senthilkumar T, Thangathirupathi A. A simple spectrophotometric method for the estimation of mecobalamin in injections. Int J Pharm Pharm Sci 2012;4:559-62.
Musenga A, Amore M, Mandrioli R, Kenndler E, Martino L de, Raggi MA. Determination of duloxetine in human plasma by capillary electrophoresis with laser-induced fluorescence detection. J Chromatogr B 2009;877:1126-32.
Hendriks MM, De Boer JH, Smilde AK, Doornbos DA. Multicriteria decision making. Chemom Intell Lab Syst 1992;16:175-91.
Sivakumar T, Manavalan R, Valliappan K. Global optimization using derringer’s desirability function: enantioselective determination of ketoprofen in the formulation and in biological matrices. Acta Chromatogr 2007;19:29-47.
Guideline on validation of analytical procedure: Text and methodology. International Conference on Harmonization ICH Q2(R1); 2005.
Mustafa G, Ahuja A, Baboota S, Ali J. Box-Behnken supported validation of stability-indicating high-performance thin-layer chromatography (HPTLC) method: an application in kinetic degradation profiling of ropinirole. Saudi Pharm J 2013; 21:93-102.
Solanki TB, Shah PA, Patel KG. Central composite design for validation of HPTLC method for simultaneous estimation of olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide in tablets. Indian J Pharm Sci 2014;76:179-87.